Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NAPROXEN EC | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2023-04-27 | 2023-06-09 | 190740 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-11-03 | 195109 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-10-11 | 195112 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-10-11 | 195207 |
| NOVAMOXIN | 250MG | TABLET (CHEWABLE) | Resolved | 2023-06-19 | 2023-08-18 | 195545 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2023-06-19 | 2023-06-27 | 195554 |
| ACT CIPROFLOXACIN | 250MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195585 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2023-06-19 | 2023-08-17 | 195629 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-20 | 2023-11-03 | 195754 |
| TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-05 | 195870 |
| TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-06 | 195894 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2023-07-06 | 2023-07-28 | 197743 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2023-08-03 | 2024-04-25 | 200864 |
| TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Actual shortage | 2023-10-12 | 2024-02-07 | 206901 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2023-10-19 | 2024-02-15 | 207500 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Actual shortage | 2023-10-19 | 2024-03-18 | 207503 |
| TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2023-10-19 | 2023-12-07 | 207539 |
| TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2023-11-03 | 2024-04-18 | 209136 |
| TEVA-NAPROXEN | 250MG | TABLET | Resolved | 2023-11-30 | 2024-01-08 | 211970 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Actual shortage | 2024-02-29 | 2024-05-09 | 220977 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 |